BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35512725)

  • 1. An integrated approach to cardioprotection in lymphomas.
    Maraldo MV; Levis M; Andreis A; Armenian S; Bates J; Brady J; Ghigo A; Lyon AR; Manisty C; Ricardi U; Aznar MC; Filippi AR
    Lancet Haematol; 2022 Jun; 9(6):e445-e454. PubMed ID: 35512725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology.
    Liang Z; He Y; Hu X
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-oncology in the older adult.
    Reddy P; Shenoy C; Blaes AH
    J Geriatr Oncol; 2017 Jul; 8(4):308-314. PubMed ID: 28499724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-oncology for Pediatric and Adolescent/Young Adult Patients.
    Tolani D; Wilcox J; Shyam S; Bansal N
    Curr Treat Options Oncol; 2023 Aug; 24(8):1052-1070. PubMed ID: 37296365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
    Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
    Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
    O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic therapies associated with cardiac toxicities: how to minimize the risks.
    Cardinale D; Stivala F; Cipolla CM
    Expert Rev Anticancer Ther; 2019 May; 19(5):359-374. PubMed ID: 30916598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
    Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
    Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Dysfunction and Chemotherapeutic Agents.
    Clasen SC; Wald JW
    Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heartbreaker: Detection and prevention of cardiotoxicity in hematological malignancies.
    Vakilpour A; Lefebvre B; Lai C; Scherrer-Crosbie M
    Blood Rev; 2024 Mar; 64():101166. PubMed ID: 38182490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer treatment-related cardiac toxicity: prevention, assessment and management.
    Fanous I; Dillon P
    Med Oncol; 2016 Aug; 33(8):84. PubMed ID: 27372782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organization and implementation of a cardio-oncology program.
    Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
    Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the risk prediction and prevention of anticancer therapy-induced cardiotoxicity.
    Bhave M; Shah AN; Akhter N; Rosen ST
    Curr Opin Oncol; 2014 Nov; 26(6):590-9. PubMed ID: 25233068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cardiac biomarkers in cardio-oncology.
    Riddell E; Lenihan D
    Curr Probl Cancer; 2018 Jul; 42(4):375-385. PubMed ID: 30126650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts.
    Biasillo G; Cipolla CM; Cardinale D
    Curr Oncol Rep; 2017 Aug; 19(8):55. PubMed ID: 28707189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of a new specialty of oncocardiology.
    Bhatt PK; Okwuosa T
    Postgrad Med J; 2017 Feb; 93(1096):59-60. PubMed ID: 27872174
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.